NVDA

176.01

+1.07%↑

AVGO.US

314.32

+1.41%↑

ORCL

145.7

-1.09%↓

MU

368.68

+9.69%↑

CSCO

78.11

+1.31%↑

NVDA

176.01

+1.07%↑

AVGO.US

314.32

+1.41%↑

ORCL

145.7

-1.09%↓

MU

368.68

+9.69%↑

CSCO

78.11

+1.31%↑

NVDA

176.01

+1.07%↑

AVGO.US

314.32

+1.41%↑

ORCL

145.7

-1.09%↓

MU

368.68

+9.69%↑

CSCO

78.11

+1.31%↑

NVDA

176.01

+1.07%↑

AVGO.US

314.32

+1.41%↑

ORCL

145.7

-1.09%↓

MU

368.68

+9.69%↑

CSCO

78.11

+1.31%↑

NVDA

176.01

+1.07%↑

AVGO.US

314.32

+1.41%↑

ORCL

145.7

-1.09%↓

MU

368.68

+9.69%↑

CSCO

78.11

+1.31%↑

Search

Globant SA

Suletud

SektorTehnoloogia

46.52 1.42

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

44.6

Max

47.38

Põhinäitajad

By Trading Economics

Sissetulek

8.5M

42M

Müük

-4.7M

612M

P/E

Sektori keskmine

19.948

74.348

Aktsiakasum

0.93

Kasumimarginaal

6.786

Töötajad

28,773

EBITDA

-2.2M

96M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+37.82% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

14. mai 2026

Turustatistika

By TradingEconomics

Turukapital

182M

2B

Eelmine avamishind

45.1

Eelmine sulgemishind

46.52

Uudiste sentiment

By Acuity

22%

78%

50 / 375 Pingereas Technology

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Globant SA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

31. märts 2026, 23:31 UTC

Kuumad aktsiad

Stocks to Watch: Nike, RH, NCino

31. märts 2026, 22:35 UTC

Tulu

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1. apr 2026, 00:00 UTC

Omandamised, ülevõtmised, äriostud

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31. märts 2026, 23:50 UTC

Omandamised, ülevõtmised, äriostud

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31. märts 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31. märts 2026, 23:33 UTC

Market Talk
Uudisväärsed sündmused

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31. märts 2026, 23:21 UTC

Tulu

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31. märts 2026, 23:14 UTC

Market Talk
Tulu

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31. märts 2026, 23:12 UTC

Market Talk

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31. märts 2026, 22:36 UTC

Tulu

China Vanke 2025 Loss Widens >000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31. märts 2026, 22:36 UTC

Tulu

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31. märts 2026, 21:46 UTC

Omandamised, ülevõtmised, äriostud

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31. märts 2026, 21:36 UTC

Market Talk

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31. märts 2026, 21:35 UTC

Tulu

Nike Expects China Sales Down 20% in 4Q, CFO Says

31. märts 2026, 21:35 UTC

Tulu

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31. märts 2026, 21:35 UTC

Tulu

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31. märts 2026, 21:33 UTC

Omandamised, ülevõtmised, äriostud

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31. märts 2026, 21:33 UTC

Tulu

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31. märts 2026, 21:32 UTC

Tulu

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31. märts 2026, 21:28 UTC

Tulu

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31. märts 2026, 21:26 UTC

Tulu

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31. märts 2026, 21:25 UTC

Tulu

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31. märts 2026, 21:24 UTC

Market Talk
Tulu

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31. märts 2026, 21:22 UTC

Tulu

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31. märts 2026, 21:22 UTC

Tulu

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31. märts 2026, 21:21 UTC

Tulu

Nike's Digital Channel Still Too Promotional, CFO Says

31. märts 2026, 21:20 UTC

Tulu

Nike CEO: Converse Remains Important to Portfolio

Võrdlus sarnastega

Hinnamuutus

Globant SA Prognoos

Hinnasiht

By TipRanks

37.82% tõus

12 kuu keskmine prognoos

Keskmine 63.55 USD  37.82%

Kõrge 78 USD

Madal 50 USD

Põhineb 13 Wall Streeti analüütiku instrumendi Globant SA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

13 ratings

5

Osta

8

Hoia

0

Müü

Tehniline skoor

By Trading Central

117.37 / N/AToetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

50 / 375 Pingereas Tehnoloogia

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

help-icon Live chat